Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
{{output}}
Introduction: RIPK1 is a critical mediator of inflammation and cell death, which is associated with extensive neurodegenerative and inflammatory diseases. Recently, RIPK1 has aroused the interests of pharmaceutical industry and r... ...
